eccogene glp-1 Non‐clinical and first‐in‐human characterization of ECC5004/AZD5004, a novel once‐daily, oral small‐molecule GLP‐1 receptor agonist - Haggag - 2025 - Diabetes, Obesity and Metabolism AstraZeneca buys rights to GLP-1
Description
Speak with Dr
Clinical features A 42-yr-old patient with Barretts esophagus underwent repeat upper gastrointestinal endoscopy and ablation of dysplastic mucosa
From tolerance to maintenance
Feeling faint on Ozempic
Expert guidance on resuming this diabetes and weight management medication post-operatively.
Ozempic, Rybelsus, and Wegovy can be life-threatening for some users
